|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | 0.00% |
| 2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
| 2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Avivagen Inc. reported earnings results for the full year ended October 31, 2021. For the full year, the company reported sales was CAD 1.3 million compared to CAD 1.18 million a year ago. Net loss was CAD 6.39 million compared to CAD 4.75 million a year ago.
Basic loss per share from continuing operations was CAD 0.12 compared to CAD 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 284K | |
| +1.40% | 10.39B | |
| +3.33% | 5.99B | |
| +22.96% | 5.53B | |
| +8.96% | 5.58B | |
| -30.03% | 2.36B | |
| +0.36% | 1.89B | |
| -25.20% | 1.1B | |
| +45.75% | 972M | |
| -17.41% | 875M |
AVIVAGEN INC. 
